
Cronos Group Inc
Healthcare · USD
Price
$2.53
Cap
$957M
Earnings
3/4 beat
30d Trend
+1%
Upper half of range — momentum is positive
Target range: $2.3 – $3.23 (consensus: $2.86)
Consensus: Hold
Earnings history
Q4 2025
BEAT
0.02 vs 0.01
Q3 2025
BEAT
0.07 vs -0.02
Q2 2025
MISS
-0.1 vs -0.02
Q1 2025
BEAT
0.02 vs
Key macro factors
Global economic slowdown and inflationary pressures: The Middle East conflict driving oil prices higher and the IMF downgrading global growth forecasts could reduce consumer discretionary spending, impacting demand for cannabis products.
Cannabis legalization and regulatory developments: Global trends in cannabis legalization, particularly in key markets like Germany and Israel (where CRON operates), and any potential shifts in US federal cannabis restrictions, are crucial for market expansion and operational flexibility.
Competition and evolving consumer preferences in the cannabis market: The rapidly changing cannabis product landscape, with new innovations in vapes and edibles, requires companies like Cronos to continuously innovate and adapt to maintain market share and appeal to diverse consumer demands.
Cronos Group Inc. is a cannabinoid company that cultivates, produces, distributes, and markets cannabis products globally, including dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under brands like Spinach, Lord Jones, Lit, and Peace Naturals.
QUANT SCORE
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.
